Education
About Us
Working with TipRanks
Follow Us
Mckesson Corp. (MCK)
NYSE:MCK
MCK Stock Chart & Stats
Day’s Range― - ―
52-Week Range$464.42 - $728.32
Previous CloseN/A
Volume137.88K
Average Volume (3M)1.10M
Market Cap
$87.69B
Enterprise Value$81.01B
Total Cash (Recent Filing)$1.13B
Total Debt (Recent Filing)$9.76B
Price to Earnings (P/E)32.1
Beta0.23
Next Earnings
May 08, 2025EPS Estimate
9.82Last Dividend Ex-Date
Mar 03, 2025Dividend Yield0.4%
Share Statistics
EPS (TTM)21.82
Shares Outstanding125,326,380
10 Day Avg. Volume875,558
30 Day Avg. Volume1,103,331
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.92
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit6.44
Enterprise Value/Ebitda16.36
Forecast
1Y Price Target
$723.00Price Target Upside3.33% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering12
---
Bulls Say, Bears Say
Bulls Say
Acquisition ImpactThe PRISM acquisition is expected to contribute an estimated $90 million in EBITDA to McKesson's 2026 pro forma post-deal adjusted EBITDA.
Earnings GrowthThe company's sustained ability to deliver on long-term EPS growth goals is a reason to justify multiple expansion that translates to stock upside from current levels.
Pharmaceutical StrengthUS Pharma is clearly exiting FY25 from a position of strength and is set up for ongoing strong EBIT growth in FY26 as utilization remains strong, specialty assets shine, and recent acquisitions contribute to growth.
Bears Say
Med-Surg PerformanceMost of the focus on the upcoming earnings is expected to be on Med-Surg, which has been challenged of late.
Prescription Technology SolutionsPrescription Technology Solutions missed modestly on EBIT.
Valuation ConcernsWhile fundamentals remain strong, the valuation feels relatively full compared to significant discounts across much of the coverage universe.
---
Ownership Overview
0.06% Insiders
23.98% Mutual Funds
0.76% Other Institutional Investors
53.92% Public Companies and
Individual Investors
MCK FAQ
What was Mckesson Corp.’s price range in the past 12 months?
Mckesson Corp. lowest stock price was $464.42 and its highest was $728.32 in the past 12 months.
What is Mckesson Corp.’s market cap?
Mckesson Corp.’s market cap is $87.69B.
When is Mckesson Corp.’s upcoming earnings report date?
Mckesson Corp.’s upcoming earnings report date is May 08, 2025 which is in 9 days.
How were Mckesson Corp.’s earnings last quarter?
Mckesson Corp. released its earnings results on Feb 05, 2025. The company reported $8.03 earnings per share for the quarter, beating the consensus estimate of $7.989 by $0.041.
Is Mckesson Corp. overvalued?
According to Wall Street analysts Mckesson Corp.’s price is currently Undervalued.
Does Mckesson Corp. pay dividends?
Mckesson Corp. pays a Quarterly dividend of $0.709 which represents an annual dividend yield of 0.4%. See more information on Mckesson Corp. dividends here
What is Mckesson Corp.’s EPS estimate?
Mckesson Corp.’s EPS estimate is 9.82.
How many shares outstanding does Mckesson Corp. have?
Mckesson Corp. has 125,326,380 shares outstanding.
What happened to Mckesson Corp.’s price movement after its last earnings report?
Mckesson Corp. reported an EPS of $8.03 in its last earnings report, beating expectations of $7.989. Following the earnings report the stock price went down -1.179%.
Which hedge fund is a major shareholder of Mckesson Corp.?
Currently, no hedge funds are holding shares in MCK
---
McKesson Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$723.00 (3.33% Upside)
$723.00 (3.33% Upside)
Blogger Sentiment
Bullish
MCK Sentiment 90%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 556.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.4%
Last 30 Days ▲ 10.5%
Last 30 Days ▲ 10.5%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
29.38%
12-Months-Change
Fundamentals
Return on Equity
51.23%
Trailing 12-Months
Asset Growth
6.87%
Trailing 12-Months
Company Description
Mckesson Corp.
McKesson Corporation is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. Founded in 1833 and headquartered in Irving, Texas, McKesson operates in various sectors, primarily focusing on the distribution of pharmaceuticals and medical products, delivering comprehensive pharmacy solutions, and offering technology-driven healthcare solutions to improve patient care and outcomes.
---
MCK Company Deck
---
MCK Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a strong financial performance with significant revenue and profit growth, driven by strategic acquisitions and expansions in specialty services. Despite challenges in the Medical Surgical segment and some revenue impacts due to formulary changes, the company's raised guidance and strong segment growth indicate a positive outlook.Read More>---
MCK Revenue Breakdown
90.22% U.S. Pharmaceutical
4.57% International
3.66% Medical-Surgical Solutions
1.54% Prescription Technology Solutions
---
MCK Stock 12 Month Forecast
Average Price Target
$723.00
▲(3.33% Upside)
Technical Analysis
---